Podiatrists in Avondale, AZ Accepting Medicare
9 Podiatrists found. Showing 1 - 9
 Desert Canyon Foot & Ankle Podiatrist Medicare: Medicare Enrolled Practice Location: 13065 W. Mcdowell Rd., Suite C101, Avondale, AZ 85392 Phone: 623-547-2800 Fax: 623-547-3083 |
 Ralph B Rabin, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 13055 W Mcdowell Rd, Suite G108, Avondale, AZ 85392 Phone: 623-846-9000 Fax: 623-846-4021 |
Dr. Sanford Martin Chesler, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 2120 N 124th Dr, Avondale, AZ 85392 Phone: 623-521-8110 Fax: 623-935-6911 |
Ralph B. Rabin Dpm Llc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 13055 W Mcdowell Rd, Suite G108, Avondale, AZ 85392 Phone: 623-846-9000 Fax: 623-846-4021 |
Integrated Medical Services Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 13065 W Mcdowell Rd, C101, Avondale, AZ 85392 Phone: 623-547-2800 Fax: 623-547-3083 |
Sanford M. Chesler, Dpm,pc Podiatrist - Foot Surgery Medicare: Not Enrolled in Medicare Practice Location: 2120 N 124th Dr, Avondale, AZ 85392 Phone: 623-521-8110 Fax: 623-935-6911 |
 Dr. Tawnya Suzanne Pfitzer, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 13065 W Mcdowell Rd, Suite A-103, Avondale, AZ 85323 Phone: 623-547-2800 Fax: 623-547-3083 |
Dr. Laurel A Robison, DPM Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 13065 W Mcdowell Rd, Suite A103, Avondale, AZ 85392 Phone: 623-547-2800 Fax: 623-547-3083 |
Premier Foot & Ankle Surgeons Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 13065 W Mcdowell Rd, Suite A 103, Avondale, AZ 85392 Phone: 623-547-2800 Fax: 623-547-3083 |
News Archive
FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency
Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today announced that the U.S. Food and Drug Administration granted Breakthrough Therapy designation to sebelipase alfa for the treatment of early onset lysosomal acid lipase deficiency, also known as Wolman disease.
Lawmakers in Conn., Calif. ready public option, single-payer bills
Lawmakers in Connecticut are considering re-introducing a bill for a public option for health insurance that died last year in the legislature. Similarly in California, state lawmakers are pushing a single-payer bill that died in the legislature last year.
La Jolla Institute for Allergy & Immunology to perform study on allergy molecular causes
A major study that will provide a new window into understanding and potentially treating allergies will be conducted by the La Jolla Institute for Allergy & Immunology (LIAI) under a $5 million federal contract.
Promising results from Cell Therapeutics' phase II OPAXIO study for advanced esophageal cancer
Cell Therapeutics, Inc. announced today that, in a study from Brown University to be presented by Howard Safran, M.D., head of the Brown University Oncology Group, in the proffered oral session at the Annual Meeting of the International Society of Gastrointestinal Oncology (ISGIO) in Philadelphia, Pennsylvania patients with cancer of the lower esophagus demonstrated a high rate of complete remission (CR) when given OPAXIO(TM) (paclitaxel poliglumex), a biologically enhanced paclitaxel, when administered in combination with standard cisplatin and concurrent radiation.
› Verified 1 days ago
Physical Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Occupational Therapists
Podiatrists